ENDRA Life Sciences Inc. — Director's Dealing 2024

Feb 23, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ENDRA Life Sciences Inc. (NDRA)
CIK: 0001681682
Period of Report: 2024-01-02

Reporting Person: Harsh Michael (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-01-02	Stock Options	$1.59	A	600	Acquired	2034-01-02	Common Stock (600)	Direct

Footnotes

F1: Represents a stock option award granted on January 2, 2024 pursuant to the Issuer's Non-Employee Director Compensation Policy.

F2: This stock option award becomes exercisable in three equal annual installments beginning January 2, 2025.